PRAMODINI MEDICARE LIMITED (SME)

Minimum Investments

₹2,64,000

Price Range

₹110 - ₹118

Issue Size

₹69.04 Cr

Lot Size

1200shares

This stock belongs to the SME (Small & Medium Enterprises) segment which usually has low liquidity and hence, is also riskier. It will be traded in a lot size of 1200 shares after listing.

Proceeds of this IPO to be used for

Funding of capital expenditure for purchase of medical equipments towards existing and proposed diagnostic centres

General corporate purposes & unidentified inorganic acquisition

Strengths & Weaknesses

Diversified models

The company provides technology-enabled diagnostic services through public-private partnerships, private hospital collaborations, PSU partnerships, and standalone centres across Tier I, II, and III cities in India. Its extensive network and hospital-based service model enable quality diagnostic services and support consistent business growth

Technical capabilities

The company leverages advanced diagnostic technology and modern equipment to deliver accurate, reliable, and efficient diagnostic services with faster turnaround times. Its strong vendor relationships, skilled technical team, and advanced imaging infrastructure support scalable operations and high-quality patient care

Diversified client base

The company serves a diversified customer base across B2B, B2C, and B2G segments, strengthening its market presence and credibility. Its patient-centric approach, standardized diagnostic centres, and focus on quality services enhance patient satisfaction, retention, and brand recognition

Specimen handling & transport risk

The company relies on proper specimen collection, packaging, transportation, and timely delivery to ensure accurate diagnostic results. Any errors, delays, damage, or contamination during these processes could affect test accuracy, increase costs, harm its reputation, and adversely impact business performance

Depend on radiology services

The company's significant reliance on radiology services exposes it to risks associated with high capital investment, equipment maintenance, and stringent regulatory requirements. Any disruption in radiology operations or non-compliance with applicable regulations could adversely affect its business, financial performance, and growth prospects

Technology innovation risk

The company's growth depends on continuously introducing new diagnostic tests, technologies, and equipment to meet evolving healthcare needs and remain competitive. Any failure to adopt new technologies, upgrade equipment, or train employees effectively could reduce testing volumes, revenue, and overall business performance

Financials

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)	Mar 2026	Y/Y Change
Operating Revenue	62.29	+62.89%
Other Income	1.09	+251.61%
Total Income	63.38	+64.41%
Total Expenditure	40.08	+75.79%
EBIDT	31.99	+50.40%
Depreciation	7.39	+72.66%
Interest	1.30	+4.84%
Tax	5.92	+28.42%
Net Profit	17.38	+57.57%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)	Mar 2026
Total Current Assets	33.07
Total Non-Current Assets	60.55
Fixed assets	44.21
Total Assets	93.62
Total Current liabilities	26.30
Total Non Current Liabilities	14.17
Total Equity Plus Liabilities	93.62
Total Shareholder Funds	53.15
Total Debt to Equity	34.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)	Mar 2026
Cash from Operating Activity	25.39
Cash from Financing Activities	5.73
Cash from Investing Activities	-30.63
Net Cash Flow	0.50

About the Company

Pramodini Medicare was incorporated on September 12, 2000. The company is a technology-enabled diagnostic service provider offering radiology, clinical laboratory, nuclear medicine, and 24×7 teleradiology services to public and private hospitals, PSUs, and medical colleges across India. Its comprehensive diagnostic solutions support disease detection, diagnosis, prevention, and monitoring through routine and specialized testing

Promoter
Chalasani Kuldeep Kumar
Promoter
Chalasani Kavitha
Promoter
Chalasani Durga Aashritha
Promoter
Chalasani Lalithakumari
Promoter
Sri Ram Medicare Private Limited

FAQs for PRAMODINI MEDICARE LIMITED IPO

PRAMODINI MEDICARE LIMITED IPO refers to the initial public offering of shares by PRAMODINI MEDICARE LIMITED. It is a process by which the company offers its shares to the public for the first time, allowing individuals to become shareholders.

For PRAMODINI MEDICARE LIMITED IPO the issue size is ₹69 Cr. The issue size is the total value of the shares offered to the public. It represents the amount the company aims to raise through the IPO.

For PRAMODINI MEDICARE LIMITED IPO the minimum investment is ₹2.6 L. The minimum investment for PRAMODINI MEDICARE LIMITED IPO is the smallest amount an individual can invest to participate in the offering. It is usually determined by the company and regulatory requirements.

For PRAMODINI MEDICARE LIMITED IPO the lot size is 1200 shares. The lot size of PRAMODINI MEDICARE LIMITED IPO refers to the number of shares that investors need to bid for and purchase in a single transaction. It is predetermined by the company and regulators.

To apply for PRAMODINI MEDICARE LIMITED IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the PRAMODINI MEDICARE LIMITED IPO from the list and click on apply now. Place your bids or choose the Cut-off Price option. Enter your UPI ID and set up your mandate to place your application.

Yes, investors can often pre-apply for some of the IPOs. Pre-application allows individuals to express their interest in participating in the IPO before the official subscription period begins. To pre- apply for PRAMODINI MEDICARE LIMITED IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the PRAMODINI MEDICARE LIMITED IPO from the list and click on pre-apply now. Once the IPO opens for subscription you can enter your UPI ID and set up your mandate to place your application.

The IPO application window typically remains open for 3 days, starting from the date of the IPO opening. However, this duration can vary depending on the specific IPO and the regulatory requirements.

You can apply for the IPO till 3 PM on the last day of application on Share.Market.

For PRAMODINI MEDICARE LIMITED IPO the allotment date is 17 Aug 2026. The allotment date of PRAMODINI MEDICARE LIMITED IPO is the date on which shares are allocated to the successful bidders. It marks the distribution of shares to investors.

For PRAMODINI MEDICARE LIMITED IPO, the subscription opens on 12 Aug 2026 and closes on 14 Aug 2026. The open and close dates of an IPO indicate the period during which investors can submit their bids to participate in the offering.